Predictors of the Response to Adalimumab in Rheumatoid Arthritis

NCT00234234 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Rouen